Found: 56
Select item for more details and to access through your institution.
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 343, doi. 10.1111/bjh.19434
- By:
- Publication type:
- Article
Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 957, doi. 10.1111/ejh.14191
- By:
- Publication type:
- Article
Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
- By:
- Publication type:
- Article
Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma—A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1168, doi. 10.3390/cancers16061168
- By:
- Publication type:
- Article
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 490, doi. 10.1007/s00259-023-06431-w
- By:
- Publication type:
- Article
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early‐stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 6, p. 881, doi. 10.1111/ejh.14093
- By:
- Publication type:
- Article
Web-Based Cognitive-Behavioral Therapy to Reduce Severe Cancer-Related Fatigue Among Survivors of Hodgkin Lymphoma: A Feasibility Study.
- Published in:
- Journal of Clinical Psychology in Medical Settings, 2023, v. 30, n. 4, p. 856, doi. 10.1007/s10880-023-09944-6
- By:
- Publication type:
- Article
Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7091, doi. 10.1007/s00432-023-04660-y
- By:
- Publication type:
- Article
Low B‐cell content is associated with a CD73‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1097, doi. 10.1111/bjh.18762
- By:
- Publication type:
- Article
Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma-a risk stratified analysis of the GHSG HD17 trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1183906
- By:
- Publication type:
- Article
Diffuse Large B-Cell Lymphoma and Related Entities: Diagnosis, Treatment, and Follow-Up.
- Published in:
- Deutsches Ärzteblatt International, 2023, v. 120, n. 17, p. 289, doi. 10.3238/arztebl.m2023.0035
- By:
- Publication type:
- Article
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 65, doi. 10.1007/s40487-022-00211-6
- By:
- Publication type:
- Article
The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 2, p. 115, doi. 10.1007/s00066-022-02035-9
- By:
- Publication type:
- Article
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 191, doi. 10.1007/s00277-022-05028-x
- By:
- Publication type:
- Article
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 728, doi. 10.1111/ejh.13859
- By:
- Publication type:
- Article
Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte‐predominant Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 382, doi. 10.1111/bjh.18376
- By:
- Publication type:
- Article
Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 801, doi. 10.1002/hon.2986
- By:
- Publication type:
- Article
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
- Published in:
- Infection, 2022, v. 50, n. 4, p. 925, doi. 10.1007/s15010-022-01765-3
- By:
- Publication type:
- Article
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e498, doi. 10.1016/j.clml.2022.01.007
- By:
- Publication type:
- Article
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Navigating increasingly individualised Hodgkin lymphoma treatments to optimally balance risks and benefits.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 5, p. 515, doi. 10.1111/bjh.18130
- By:
- Publication type:
- Article
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high‐grade B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 5, p. 403, doi. 10.1111/ejh.13747
- By:
- Publication type:
- Article
Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e5, doi. 10.1111/bjh.17997
- By:
- Publication type:
- Article
Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 606, doi. 10.1111/bjh.17878
- By:
- Publication type:
- Article
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 1, p. 81, doi. 10.1080/0284186X.2021.1986230
- By:
- Publication type:
- Article
Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 99, doi. 10.1111/bjh.17770
- By:
- Publication type:
- Article
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 116, doi. 10.1111/bjh.17793
- By:
- Publication type:
- Article
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX‐based regimens in clinical routine.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 2, p. 202, doi. 10.1111/ejh.13639
- By:
- Publication type:
- Article
Moving the goalposts while scoring―the dilemma posed by new PET technologies.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients – An Analysis of GHSG HD14- and HD17-Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.658358
- By:
- Publication type:
- Article
Non‐Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 515, doi. 10.1111/bjh.17327
- By:
- Publication type:
- Article
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.
- Published in:
- 2020
- By:
- Publication type:
- journal article
How I treat advanced Hodgkin lymphoma — a global view.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 837, doi. 10.1111/bjh.16587
- By:
- Publication type:
- Article
FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 601, doi. 10.3390/cancers12030601
- By:
- Publication type:
- Article
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 5, p. 1783, doi. 10.3390/ijerph17051783
- By:
- Publication type:
- Article
Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S251, doi. 10.1016/j.clml.2019.07.158
- By:
- Publication type:
- Article
BELINDA: A Phase 3 Study Evaluating the Safety and Efficacy of Tisagenlecleucel versus Standard of Care in Adult Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S270, doi. 10.1016/j.clml.2019.07.197
- By:
- Publication type:
- Article
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 42, doi. 10.1111/bjh.15741
- By:
- Publication type:
- Article
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 42, doi. 10.1111/bjh.15741
- By:
- Publication type:
- Article
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 207, doi. 10.2967/jnumed.118.210047
- By:
- Publication type:
- Article
PET-guided Treatment in Patients with Advanced-stage Hodgkin's Lymphoma (HD18): Final Results of An Open-label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.
- Published in:
- Indian Journal of Chest Diseases & Allied Sciences, 2018, v. 60, n. 1, p. 44
- By:
- Publication type:
- Article
Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)—An Interim Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S373, doi. 10.1016/j.clml.2017.07.213
- By:
- Publication type:
- Article
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179124
- By:
- Publication type:
- Article
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 547, doi. 10.1111/bjh.13646
- By:
- Publication type:
- Article
Sixteenth Biannual Report of the Cochrane Haematological Malignancies Group: Focus on Non-Hodgkin’s Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju170
- By:
- Publication type:
- Article
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 12, p. 2829, doi. 10.1002/ijc.28609
- By:
- Publication type:
- Article
The Effect of Specialized Cancer Treatment Centers on Treatment Efficacy in Hodgkin's Lymphoma.
- Published in:
- Deutsches Ärzteblatt International, 2012, v. 109, n. 51/52, p. 893, doi. 10.3238/arztebl.2012.0893
- By:
- Publication type:
- Article
The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 3, p. 164, doi. 10.1007/s11899-011-0089-7
- By:
- Publication type:
- Article